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Abstract
Introduction: Well-documented cases of untreated cervical intra-epithelial dysplasia resulting in fatal progression of
invasive cervical cancer are scarce because of a long pre-invasive state, the availability of cervical cytology
screening programs, and the efficacy of the treatment of both pre-invasive and early-stage invasive lesions.
Case presentation: We present a well-documented case of a 29-year-old Caucasian woman who was found,
through routine conventional cervical cytology screening, to have pathologic Papanicolaou (Pap) grade III D lesions
(squamous cell abnormalities). She subsequently died as a result of human papillomavirus type 18-associated
cervical cancer after she refused all recommended curative therapeutic procedures over a period of 13 years.
Conclusion: This case clearly demonstrates a caveat against the promotion and use of complementary alternative
medicine as pseudo-immunologic approaches outside evidence-based medicine paths. It also demonstrates the
impact of the individualized demands in diagnosis, treatment and palliative care of patients with advanced cancer
express their will to refuse evidence-based treatment recommendations.
Introduction
Cases of intra-epithelial disease of the cervix are almost
entirely attributable to human papillomavirus (HPV)
infection. A minority of women exposed to HPV develop
a persistent infection that affects the squamocolumnar
junction where the ectocervix and endocervix meet.
Within that junction, dynamic changes of the epithelium
occur due to puberty, pregnancy, menopause and hormo-
nal stimulation. The epithelium is vulnerable to noxae
associated with smoking, contraceptive use and infection
with other sexually transmitted diseases. Alterations of
the epithelium are assessed by conventional cervical
cytology screening and are scored according to either the
Bethesda or the Papanicolaou system. The occurrence of
reactive changes and/or cell abnormalities triggers either
repetitions of the cytology screening to exclude tempor-
ary alterations or a cervical biopsy for histological diag-
nosis of cervical intra-epithelial neoplasia and cervical
cancer. With the advent of HPV vaccination [1] and HPV
screening [2] to identify women at risk of lesions with
atypical or malignant cells prior to clinical manifestation,
in current clinical practice a patient’sH P Vs t a t u ss h o u l d
play a central role in the prevention of HPV-associated
diseases [3].
Invasive cervical cancer has a long pre-invasive state,
and cervical cytology screening programs are available.
Moreover, HPV vaccination has been shown to be a
successful tool of primary prevention [1], and treatment
of pre-invasive lesions is effective. Invasive cancer is
considered a preventable cancer in the so-called highly
developed Western countries [3]. Consequently, invasive
cancer of the cervix has become increasingly infrequent
in this part of the world, but it remains a significant
health problem in underdeveloped countries, where
meticulous documentation of fatal courses of the disease
plays a minor role. Thus, our knowledge of the lead
time between dysplasia and the development of invasive
cancer as well as progression from early-stage to metas-
tasized cancer largely derives from extrapolating infor-
mation from studies and textbooks, but very few case
reports.
Herein we report a rather rare, yet well-documented
case of a 29-year-old woman who, during the course of
her disease, accepted multiple diagnostic procedures but
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assessment of cervical dysplasia and early-stage invasive
cancer 10 years later. She finally refused to accept any
interventional medical strategies, except for palliative
care, at the stage of locally progressed and metastasized
cervical cancer.
Case presentation
A 29-year-old Caucasian woman was seen for her rou-
tine annual gynecologic examination, and conventional
cytological screening of her cervix uteri revealed a
pathologic finding scored as grade IIID under the Papa-
nicolaou system. Repeat screening performed one year
later revealed a grade IV pathologic finding, suggesting a
high-grade squamous intra-epithelial lesion. Our patient
refused the recommended diagnostic and therapeutic
procedure of conization, and she was placed on a non-
specified homeopathic therapy consisting of a vitamin
C-containing regimen and subcutaneous administration
of mistletoe lectins.
A tt h et i m eo ft h ef i r s tp a t h o logic Papanicolaou test,
our patient reported a normal menstrual cycle, no preg-
nancies, no use of oral contraceptives, no presence of
any previous diseases or any surgery, no allergies, no
smoking, and no use of illicit drugs. There was no evi-
dent lack in body hygiene. Except for her father’ss t o -
mach cancer, her family and cancer-specific anamneses
were unremarkable. On the basis of her grade V in
Papanicoleau test, she was sent to our hospital’so u t -
patient department.
A gynecologic examination at that time revealed
obvious tumor growth confined to her cervix with no
signs of extension to her vagina. A cervical biopsy
showed moderately differentiated (tumor grade II) large-
cell non-keratinizing squamous cell carcinoma of the
cervix uteri. Neither lymphatic nor venous vascular
space involvement was reported, but dense inflamma-
tory cell infiltration of the tumor stroma was noted.
Clinical staging was completed by cystoscopy, procto-
scopy, and chest radiography (as allowed for accurate
clinical staging by the International Federation of Gyne-
cology and Obstetrics [FIGO]), which revealed stage IB2
cancer. Additional information was obtained by
extended staging procedures, including computed tomo-
graphic (CT) and laparoscopic sampling of her para-aor-
tic lymph nodes (the results of which would have had
no influence on the assigned clinical stage according to
FIGO guidelines).
However, our patient refused to undergo any further
diagnostic procedures and instead underwent comple-
mentary medical treatment. This included regional
hyperthermia, which led to her self-admission to a local
hospital. She presented there with reduced physical sta-
tus, large edema of the legs, and moist rales in her
lungs. She also reported lower abdominal pain. Her clin-
ical work-up revealed significant progression of her dis-
ease, which now included bilateral parametrial
involvement, broad involvement of her dorsal bladder
wall, infiltration of her outer rectum wall, pericardial
and pleural effusion, bilateral hydronephrosis with
laboratory signs of uremia (serum creatinine 17.4 mg/
dL, serum uric acid 106 mg/dL), and tumor anemia
with hemoglobin at 71 g/L. Two courses of hemodialysis
were performed initially, followed by a right-sided
nephrostomy after the failure of ureteral stenting due to
tumor extension to her bladder. It was decided to com-
mence hemodialysis on the basis of the patient’s request
for consequent evidence-based, palliative medical care
after restoration of her renal function.
Restaging was performed, which indicated involvement
of her bladder wall and adhesions to the ileocecal area
(Figure 1b). All three para-aortic lymph nodes removed
during re-laparoscopy were positive (Figures 1c and 1d),
while no signs of distant metastasis were seen on the
radiologic studies. The tumor was restaged to FIGO
IVa, and concurrent cisplatin-based chemoradiation was
recommended. Our patient, however, opted against our
treatment recommendation and traveled to the Philip-
pines for an alternative holistic treatment schedule
involving several courses of Horvi-Reintoxin enzyme
therapy, which consists of enzymatically processed snake
poison that is purported to specifically inhibit glycosyla-
tion in tumor cells, thus conferring anti-tumoral activity.
Our patient was repeatedly admitted to both Brixen
and Innsbruck hospitals for erythrocyte transfusions
because of spontaneous uterine hemorrhage and further
local tumor progression (Figure 2a). Acute life-threaten-
ing hemorrhage prompted us to perform three sessions
of arterial embolization: first, in both uterine arteries;
second, in both internal pudendal arteries and re-embo-
lization of her right uterine artery; and third, in her
right superior and inferior vesical arteries and re-embo-
lization of her left internal pudendic artery. In parallel,
our patient continued her holistic alternative medical
treatment, first with active fever treatment, during
which pyrogenic lysates of bacteria were administered
and second with combined application of Carnivora-
Mistletoe-Ukrain (that is, capsules with plant extracts,
subcutaneous injections of mistletoe lectins, capsules
with extracts of celandine and Chelidonium majus), all
of which are purported to have antitumoral activity.
Seven months later our patient was admitted to the
hospital with clinical signs of chronic large bowel
obstruction, and laparotomy and side-to-side ileoascen-
dostomy became necessary, during which her left ureter
(Figure 2b), descending colon, rectosigmoid and ileoce-
cum appeared fixed by tumor masses and obstructed by
large, lymphatic fluid-containing cysts (Figure 2c). Our
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recovered fairly well. However, during the following
days, palliative care was required for salvage from dys-
pnoea by bilateral pleuracentesis (Figure 2d), from
mechanical and paralytic small and large bowel
obstruction by distigmine bromide administration, and
from recurrent visceral abdominal and neurogenic pain
by morphine hydrochloride. On the basis of a CT scan,
a paralytic ileus, together with metastasis to her spleen
(Figure 2e) and her liver (Figure 2f), were diagnosed.
One month later our patient died as a result of tumor
cachexia, chronic small and large bowel ileus, septicemia
and consecutive multiple organ failure. In her last will,
she refused autopsy.
For HPV testing, we isolated DNA from the paraffin-
embedded tumor shown in Figure 1a. With group-speci-
fic nested polymerase chain reactions for the detection
of a-HPV DNA [4], we tested for the presence of 18
high-risk HPV types (16, 18, 26, 31, 33, 35, 39, 45, 51,
52, 53, 56, 58, 59, 66, 68, 73, and 82) and 18 low-risk
HPV types (6, 11, 40, 42, 43, 44, 34, 54, 55, 57, 61, 70,
71, 72, 81, 83, 84, and 89). Our patient’s tumor exclu-
sively contained type 18 HPV DNA.
Discussion
We have presented the case of a woman who had a
pathologic cervical cytology screening at the age of 29
years, and died as a result of cervical cancer at the age
of 42 after she had denied all recommended curative
therapeutic procedures for 13 years. Except for the
noted HPV type 18 infection, our patient’sd e m o g r a p h i c
characteristics included the typical socioeconomic and
epidemiologic risk factors known for cervical cancer in
that she was Caucasian, had a high socioeconomic sta-
tus, reported no cigarette smoking, was nulliparous and
reported no history of apparent promiscuity. It appears
t ob ear a t h e rr a r ec a s ei nt e r m so f ,o nt h eo n eh a n d ,
accepting far-reaching diagnostic procedures such as
laparoscopic lymph node sampling, and on the other,
consistently refusing to accept all proposed evidence-
based treatment recommendations over a total period of
13 years, with no psychological disorder being apparent.
Documented cases of untreated cervical dysplasia are
rare, and ours appears to be only the second report pub-
lished during the past 10 years that is retrievable in the
currently available medical literature databases. The
other case, reported in 2002, described a very short
interval of one year between the diagnosis of cervical
dysplasia and metastases in the bone, liver, and orbit
[5]. This short interval between dysplasia and metastatic
cervical cancer, however, raises questions as to whether
the Pap smear was representative or whether invasive
cancer was missed. Thus, our case presentation might
be one of the very few examples of a complete clinical
documentation of such “natural” progression among
retrievable case reports in the medical literature.
Of note, we want to stress that the apparent inefficacy
of the complementary alternative medical treatments
practiced worldwide, which should have exerted a
Figure 1 Restaging of the tumor. (a) formalin-fixed, paraffin-embedded
biopsy of the invasive cervix cancer; (b) corresponding CT scan of the
pelvis; (c) formalin-fixed, paraffin-embedded biopsy of the para-aortic lymph
node metastases and her abdomen showing bladder invasion; and (d)
corresponding CT scan of the enlarged para-aortic lymph nodes.
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antineoplastic influence. Effects in preventing high-grade
cervical lesions to date have been noted only for bivalent
and quadrivalent vaccines against HPV type 16 or 18
and HPV types 6, 11, 16, and18, with vaccine efficacies
well above 90% [1]. Remarkably, and in sharp contrast
to the mentioned vaccine efficacy, the non-specific
approaches used in complementary alternative medicine,
as described in our present case, are deemed rather
inefficacious.
HPV type 16 or 18 infections are responsible for
approximately 60-80% of all invasive cancers, varying
according to the patient’s socioeconomic status [6]. Of
all new HPV infections, both oncogenic and non-onco-
genic type infections last between eight and five months,
respectively, and the large majority of initially HPV-
infected women show clearance within two years [7].
Pre-invasive surrogate lesions of squamous cervical can-
c e rw o u l db et h o s eo fg r a d eI Ia n dI I I ,w i t ht h el o w e s t
potential of regression being that for grade III cervical
intra-epithelial neoplasia [8]. Since our patient refused
histopathological verification of the first cytological
abnormalities in 1993, we were unable to determine
whether a single, persistent HPV type 18 infection gave
rise to her cervical cancer, which was diagnosed in
2003. The assumption that this was the case is highly
likely to be true, since progression from HPV infection
to invasive cancer is believed to take place during the
course of several years, although we cannot exclude
HPV type 18 reinfection after initial clearance. Cervical
precursor lesions of oncogenic HPV infections, such as
HPV type 18 in our case, are known to persist longer
and progress more often than non-oncogenic type infec-
tions [9]. The likelihood of regression, stable dysplasia
or progression from moderate cervical dysplasia (CIN II,
which could have been the underlying disease in our
patient, who had Pap IIID and Pap IV) is known to be
almost equal. Because progression lead times are usually
in the two- to five-year range [10], even if we take into
account a potential reinfection as well as some time for
progression from the first invasion to the bulky disease
(on which we have no firm information available), in
our case a gradual escape of the tumor from the host’s
immune surveillance may explain the rather slow pro-
gression to bulky cervix cancer over a ten-year period.
This ten-year period of uninfluenced tumor growth
also allowed for systemic spread and a pattern of distant
metastasis that, to the best of our knowledge, has not
thus far been reported in the literature, but suggests a
much more complex homing pattern of disseminated
tumor cells. Overall, cervical cancer has a low propen-
sity for distant hematogenous metastatic spread. The
first clinical sign of metastasis to para-aortic lymph
nodes, that is, beyond the true pelvis, was assessed after
10 years on the basis of a CT scan. Furthermore, the
most common sites of distant metastasis are the lung,
liver, bone and, rarely, the peritoneum. Single reports
would add the orbit [5] and bone marrow [11]. Our
patient’s liver and spleen metastasis as well as carcinosis
peritonei shortly before her death are rarely seen, but
Figure 2 CT scans. (a) local tumor progression in her pelvis and vesical invasion and hemorrhage; (b) left ureter obstruction; (c) ileus through
descending colon and rectosigmoid obstruction; (d) malignant pleural effusion; (e) spleen metastasis; (f) liver metastasis.
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spread in cervical cancer.
Conclusion
In summary, we have presented an unusual case of
untreated, presumably HPV type 18-induced cervical
dysplasia with progression to invasive and finally meta-
static cervical cancer that demonstrated a ten-year lead
time between the diagnosis of dysplasia and invasive
cancer. This case serves as a caveat against the promo-
tion and use of complementary alternative medicine as
pseudo-immunologic approaches outside evidence-based
medicine paths. It also highlights the individualized
demands in diagnosis, treatment and palliative care of
advanced cancer patients who express their will to
refuse evidence-based treatment recommendations.
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